Edwards Lifesciences Resolves $140 Million Harpoon Medical Case

Edwards Lifesciences Corp. has resolved a court case seeking up to $140 million over claims it failed to commercialize a heart valve device it gained in its acquisition of Harpoon Medical Inc.

The cardiac equipment maker and former Harpoon investors, who sued through a shareholder services firm, said in a Dec. 12 filing that they’d ended their dispute on undisclosed terms. The lawsuit, filed last year, said Edwards breached a purchase agreement provision accelerating post-deal payments if it dropped development for reasons unrelated to safety and efficacy.

The apparent last-minute settlement scuttled a trial that had been set to ...